Drug class
Glutamatergic/GABAergic neuromodulator; synthetic taurine analogue used in alcohol-dependence relapse prevention
Mechanism of action
The exact mechanism by which acamprosate supports maintenance of abstinence is not fully understood. Experimental data suggest modulation of glutamatergic (particularly NMDA-related) and GABAergic neurotransmission during alcohol withdrawal-related neuroadaptation; these pathways should be presented as proposed rather than confirmed clinical targets.
General use cases
- Maintenance of alcohol abstinence in adults with alcohol dependence who are abstinent when treatment is initiated; use as part of a comprehensive psychosocial treatment programme. It does not treat acute alcohol withdrawal.
For general informational purposes only. Do not rely on, cross-reference, cite or use this information as evidence or support for legal, regulatory, commercial or other claims.
